• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Alembic Pharmaceuticals Limited — Updates, 26-06-2026: Press Release

    26-06-2026 | 10:31 am

    Alembic Pharma secures US approval for Oseltamivir Phosphate Oral Suspension, a Tamiflu generic. This targets an annual market of US$ 27 million, boosting their US generics portfolio.

    No comments yet. Be the first to comment!

    All announcements from Alembic Pharmaceuticals Limited